Germany
· Delayed Price · Currency is EUR Bio-Gate AG Statistics
Total Valuation
Bio-Gate AG has a market cap or net worth of EUR 8.22 million. The enterprise value is 7.81 million.
| Market Cap | 8.22M |
| Enterprise Value | 7.81M |
Important Dates
The last earnings date was Monday, September 9, 2024.
| Earnings Date | Sep 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio-Gate AG has 9.24 million shares outstanding.
| Shares Outstanding | 9.24M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +3.14% |
| Owned by Insiders (%) | 3.41% |
| Owned by Institutions (%) | 2.00% |
| Float | 2.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.90 |
| EV / Sales | 1.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.82 |
Financial Position
The company has a current ratio of 2.59
| Current Ratio | 2.59 |
| Quick Ratio | 0.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.77 |
Financial Efficiency
Return on equity (ROE) is -68.91% and return on invested capital (ROIC) is -39.06%.
| Return on Equity (ROE) | -68.91% |
| Return on Assets (ROA) | -25.84% |
| Return on Capital (ROIC) | -39.06% |
| Revenue Per Employee | 180,283 |
| Profits Per Employee | -47,691 |
| Employee Count | 42 |
| Asset Turnover | 1.59 |
| Inventory Turnover | 2.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -1.11% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 1.00 |
| Relative Strength Index (RSI) | 46.71 |
| Average Volume (20 Days) | 150 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio-Gate AG had revenue of EUR 7.57 million and -2.00 million in losses.
| Revenue | 7.57M |
| Gross Profit | 3.82M |
| Operating Income | -1.97M |
| Pretax Income | -2.03M |
| Net Income | -2.00M |
| EBITDA | -1.72M |
| EBIT | -1.97M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | 475,997 |
| Total Debt | n/a |
| Net Cash | 475,997 |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 2.35M |
| Book Value Per Share | n/a |
| Working Capital | 1.54M |
Cash Flow
In the last 12 months, operating cash flow was -1.03 million and capital expenditures -115,000, giving a free cash flow of -1.15 million.
| Operating Cash Flow | -1.03M |
| Capital Expenditures | -115,000 |
| Free Cash Flow | -1.15M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 50.42%, with operating and profit margins of -26.02% and -26.45%.
| Gross Margin | 50.42% |
| Operating Margin | -26.02% |
| Pretax Margin | -26.81% |
| Profit Margin | -26.45% |
| EBITDA Margin | -22.76% |
| EBIT Margin | -26.02% |
| FCF Margin | -15.12% |
Dividends & Yields
Bio-Gate AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | -13.92% |
Stock Splits
The last stock split was on November 26, 2012. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.25 |